期刊
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
卷 18, 期 4, 页码 551-558出版社
SPRINGER TOKYO
DOI: 10.1007/s00534-010-0368-z
关键词
Traditional Chinese medicine; Sinisan; Chronic pancreatitis; Trinitrobenzene sulfonic acid
资金
- Chinese Government [2009659015]
Sinisan, a traditional Chinese medicine, is effective for the treatment of gastrointestinal disorders. In this study, we investigated the potential protective role of Sinisan against chronic pancreatitis (CP) in rats. CP was induced in rats by intrapancreatic injection of trinitrobenzene sulfonic acid (TNBS). Rats were randomly divided into a sham group, a TNBS-induced CP group and a Sinisan-treated group. Serum amylase and histological score were used to evaluate the severity of disease. The levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), cyclooxygenase-2 (COX-2), interleukin-10 (IL-10) and alpha-smooth muscle actin (alpha-SMA) were also measured in the three groups. Mechanical allodynia was measured with von Frey filaments. In addition, the protein levels of nerve growth factor (NGF) were measured in pancreatic tissues. Administration of Sinisan significantly decreased the severity of CP. In the Sinisan-treated group, serum amylase, TNF-alpha, IL-1 beta, COX-2 and alpha-SMA levels were lower and the level of IL-10 was upregulated compared with the TNBS-induced CP group. Furthermore, treatment with Sinisan significantly, though not completely, attenuated the allodynia. Simultaneously NGF expression was also significantly downregulated in the Sinisan-treated group compared with the TNBS-induced CP group. Sinisan could be an effective treatment modality for CP via its anti-inflammatory, anti-fibrotic and analgesic properties. It may be a promising drug candidate for the treatment of patients with CP.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据